Skip to main content
Arcellx, Inc. (ACLX)
NASDAQ: ACLX · IEX Real-Time Price · USD
52.00
-0.24 (-0.46%)
At close: May 31, 2024, 4:00 PM
53.30
+1.30 (2.50%)
After-hours: May 31, 2024, 5:56 PM EDT

Arcellx Revenue

Arcellx had revenue of $131.66M in the twelve months ending March 31, 2024, with 635.05% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $39.26M with 119.16% year-over-year growth. In the year 2023, Arcellx had annual revenue of $110.32M.

Revenue (ttm)
$131.66M
Revenue Growth
+635.05%
P/S Ratio
21.13
Revenue / Employee
$1,012,792
Employees
130
Market Cap
2.78B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023110.32M--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PTC Therapeutics 927.56M
GoodRx Holdings 764.16M
Azenta 651.76M
10x Genomics 625.45M
iRhythm Technologies 513.17M
Amicus Therapeutics 423.49M
Denali Therapeutics 295.39M
MorphoSys AG 264.75M
Revenue Rankings

ACLX News

More News